December 10, 2015
Jörg has succeeded to raise 1.5 million euro with the ERC starting grant for research on cell cycle and redox system!
"Funded by the ERC Starters grant we will now investigate how cell cycle and redox systems interact in healthy cells and will subsequently unravel the nodes between the two systems cancer cells can hijack. The ongoing controversy over antioxidants in cancer therapy illustrates the need of a better understanding of cell cycle and redox biology”, explains Jörg Mansfeld. While supplementation of antioxidants in chemotherapy long has been thought to prevent cancer, recent discoveries in contrast suggest that they might also protect cancer cells from an increased and toxic production of ROS. “Shedding light on the cell cycle targets of ROS in proliferating cells we aim to provide a significantly improved basis for ROS signaling during tumorigenesis and thereby might indicate new strategies for treatment”, says Jörg.
Here you can read more about the project and Jörg's plans on TU Dresden website.